Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.
about
Intestinal microbiota, probiotics and mental health: from Metchnikoff to modern advances: Part II - contemporary contextual researchInflammation and Oxidative Stress: The Molecular Connectivity between Insulin Resistance, Obesity, and Alzheimer's DiseaseLymphatics in Neurological Disorders: A Neuro-Lympho-Vascular Component of Multiple Sclerosis and Alzheimer's Disease?Lipopolysaccharide-induced middle ear inflammation disrupts the cochlear intra-strial fluid-blood barrier through down-regulation of tight junction proteins.The gut-brain axis: is intestinal inflammation a silent driver of Parkinson's disease pathogenesis?N-acetyl cysteine in the treatment of obsessive compulsive and related disorders: a systematic reviewMagnesium sulfate treatment reverses seizure susceptibility and decreases neuroinflammation in a rat model of severe preeclampsia.Blood-brain barrier dysfunction as a cause and consequence of Alzheimer's disease.T Lymphocytes and Inflammatory Mediators in the Interplay between Brain and Blood in Alzheimer's Disease: Potential Pools of New Biomarkers.Dendrimer brain uptake and targeted therapy for brain injury in a large animal model of hypothermic circulatory arrest.Peroxisome proliferator-activated receptors and Alzheimer's disease: hitting the blood-brain barrier.Drug access to the central nervous system in Alzheimer's disease: preclinical and clinical insights.Nanomedicine in the ROS-mediated pathophysiology: Applications and clinical advances.Lipopolysaccharide-induced blood-brain barrier disruption: roles of cyclooxygenase, oxidative stress, neuroinflammation, and elements of the neurovascular unit.Expression and Processing of Amyloid Precursor Protein in Vascular Endothelium.Role of LRP1 in the pathogenesis of Alzheimer's disease: evidence from clinical and preclinical studies.Probenecid, an organic anion transporter 1 and 3 inhibitor, increases plasma and brain exposure of N-acetylcysteine.Central and peripheral administration of antisense oligonucleotide targeting amyloid-β protein precursor improves learning and memory and reduces neuroinflammatory cytokines in Tg2576 (AβPPswe) mice.Dose escalation study of intravenous and intra-arterial N-acetylcysteine for the prevention of oto- and nephrotoxicity of cisplatin with a contrast-induced nephropathy model in patients with renal insufficiency.The Post-Anaesthesia N-acetylcysteine Cognitive Evaluation (PANACEA) trial: study protocol for a randomised controlled trial.Treatment effect of coenzyme Q(10) and an antioxidant cocktail in fibroblasts of patients with Sanfilippo disease.Expression and function of Abcg4 in the mouse blood-brain barrier: role in restricting the brain entry of amyloid-β peptideRole of 3-Acetyl-11-Keto-Beta-Boswellic Acid in Counteracting LPS-Induced Neuroinflammation via Modulation of miRNA-155.Nutritional habits, risk, and progression of Parkinson disease.Neuroprotective effect of peptides extracted from walnut (Juglans Sigilata Dode) proteins on Aβ25-35-induced memory impairment in mice.Neuroimmune Axes of the Blood-Brain Barriers and Blood-Brain Interfaces: Bases for Physiological Regulation, Disease States, and Pharmacological Interventions.
P2860
Q21198786-85B63E78-983E-4543-B682-CF093D1886E8Q26773657-73C901AE-91BA-4F50-892C-545C41F0E5B3Q30275974-A7C5E228-DDCD-4D36-BCC2-E340EA9E5371Q30414927-257192B7-7C55-4931-96BC-E852AE901E15Q33731341-242CB078-25F1-4EFB-82C5-66A2C2A36EFFQ34473631-FC4E5AAE-6AA1-4C38-A31D-84E6FF055420Q34542820-9B1159D1-9FC1-4895-97B8-2DD11B926BEEQ37216153-A12F7DA9-234F-441E-8C6B-796AE238BBC2Q37672845-DCD73B46-8E5B-4E7C-B19C-F0830278863FQ37731623-2BB8295D-D153-47D3-B3AB-3B83B5BE576CQ38089668-C5E9593A-D88B-431C-A06B-97AC4B8DD8D9Q38260539-548C01BA-54F6-49B6-A127-768C3E0A9CA2Q38563026-15E8457B-1A68-4C52-9173-8F5EFD9059BFQ38816544-CFF8028C-39AD-4682-870D-009A0AD42BD0Q39032252-968AE101-C30E-448D-9EC0-4C334490E077Q39222720-8D7398ED-E14A-4C2D-87A0-78F139D6B8FBQ39698411-9BB9E7CA-22B7-4141-9DAE-941BE349B502Q42123997-770C96BB-FE62-4B17-B30E-B83FE8558D09Q42281143-1E91605D-F1E4-4355-8EBB-E150E1EC535BQ42371638-D2485F96-BB47-4E87-933F-748D3177D3DFQ42451148-43FC65CB-D096-447F-834B-E1673DDFEECFQ42657132-6D464A5A-C9A2-43B8-8F52-B7C6292CF809Q46159726-76BEA0A1-1FD1-4904-9F3F-4C4E65124440Q48024631-8DC6ABDA-52B2-47B1-922B-4CDA30A28D52Q48932169-2A467FCF-3916-4677-911A-CC75C87D840FQ52689036-19B9C4E3-3E51-470A-9958-5FC5EE74A6B0
P2860
Inflammation-induced dysfunction of the low-density lipoprotein receptor-related protein-1 at the blood-brain barrier: protection by the antioxidant N-acetylcysteine.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Inflammation-induced dysfuncti ...... antioxidant N-acetylcysteine.
@ast
Inflammation-induced dysfuncti ...... antioxidant N-acetylcysteine.
@en
type
label
Inflammation-induced dysfuncti ...... antioxidant N-acetylcysteine.
@ast
Inflammation-induced dysfuncti ...... antioxidant N-acetylcysteine.
@en
prefLabel
Inflammation-induced dysfuncti ...... antioxidant N-acetylcysteine.
@ast
Inflammation-induced dysfuncti ...... antioxidant N-acetylcysteine.
@en
P2860
P921
P1476
Inflammation-induced dysfuncti ...... antioxidant N-acetylcysteine.
@en
P2093
Kim Hansen
Michelle A Erickson
P2860
P304
P356
10.1016/J.BBI.2012.07.003
P577
2012-07-15T00:00:00Z